p.115 抽出テキスト

2003; 67: 8-10. PMID: 12520143 423. Takagi M, Yokoyama Y, Aonuma K, et al. Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. Clinical characteristics and risk stratification in symptomatic and asymptomatic patients with brugada syndrome: multicenter study in Japan. J Cardiovasc Electrophysiol 2007; 18: 1244-1251. PMID: 17900255 424. Junttila MJ, Brugada P, Hong K, et al. Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients. J Cardiovasc Electrophysiol 2008; 19: 380-383. PMID: 18081770 425. Babai Bigi MA, Aslani A, Shahrzad S. aVR sign as a risk factor for life-threatening arrhythmic events in patients with Brugada syndrome. Heart Rhythm 2007; 4: 1009-1012. PMID: 17675073 426. deleted in proof. 427. Wada T, Nagase S, Morita H, et al. Incidence and Clinical Significance of Brugada Syndrome Masked by Complete Right Bundle-Branch Block. Circ J 2015; 79: 2568-2575. PMID: 26447120 428. Morimoto Y, Morita H, Ejiri K, et al. Significant Delayed Activation on the Right Ventricular Outflow Tract Represents Complete Right Bundle-Branch Block Pattern in Brugada Syndrome. J Am Heart Assoc 2023; 12: e028706. PMID: 37158059 429. Vitali F, Brieda A, Balla C, et al. Standard ECG in Brugada Syndrome as a Marker of Prognosis: From Risk Stratification to Pathophysiological Insights. J Am Heart Assoc 2021; 10: e020767. PMID: 33977759 430. Ikeda T, Abe A, Yusu S, et al. The full stomach test as a novel diagnostic technique for identifying patients at risk of Brugada syndrome. J Cardiovasc Electrophysiol 2006; 17: 602-607. PMID: 16836706 431. Nishizaki M, Sakurada H, Mizusawa Y, et al. Influence of meals on variations of ST segment elevation in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2008; 19: 62-68. PMID: 17900254 432. Ajiro Y, Hagiwara N, Kasanuki H. Assessment of markers for identifying patients at risk for life-threatening arrhythmic events in Brugada syndrome. J Cardiovasc Electrophysiol 2005; 16: 45-51. PMID: 15673386 433. Huang Z, Patel C, Li W, et al. Role of signal-averaged electrocardiograms in arrhythmic risk stratification of patients with Brugada syndrome: a prospective study. Heart Rhythm 2009; 6: 1156-1162. PMID: 19632627 434. Brito J, Cortez-Dias N, da Silva GL, et al. Association between the number of altered late potential criteria and increased arrhythmic risk in Brugada syndrome patients. J Interv Card Electrophysiol 2024; 67: 1133-1143. PMID: 37966657 435. Junttila MJ, Gonzalez M, Lizotte E, et al. Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation 2008; 117: 1890-1893. PMID: 18391123 436. Michowitz Y, Milman A, Sarquella-Brugada G, et al. Fever-related arrhythmic events in the multicenter Survey on Arrhythmic Events in Brugada Syndrome. Heart Rhythm 2018; 15: 1394-1401. PMID: 29649615 437. Probst V, Denjoy I, Meregalli PG, et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation 2007; 115: 2042-2048. PMID: 17404158 438. Chockalingam P, Clur SA, Breur JM, et al. The diagnostic and therapeutic aspects of loss-of-function cardiac sodium channelopathies in children. Heart Rhythm 2012; 9: 1986-1992. PMID: 22885917 439. Letsas KP, Liu T, Shao Q, et al. Meta-Analysis on Risk Stratification of Asymptomatic Individuals With the Brugada Phenotype. Am J Cardiol 2015; 116: 98-103. PMID: 25933735 440. Morita H, Miyamoto M, Watanabe A, et al. Progression of electrocardiographic abnormalities associated with initial ventricular fibrillation in asymptomatic patients with Brugada syndrome. Heart Rhythm 2018; 15: 1468-1474. PMID: 29953954 441. Take Y, Morita H, Toh N, et al. Identification of high-risk syncope related to ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm 2012; 9: 752-759. PMID: 22123317 442. Sacher F, Arsac F, Wilton SB, et al. Syncope in Brugada syndrome patients: prevalence, characteristics, and outcome. Heart Rhythm 2012; 9: 1272-1279. PMID: 22504046 443. Olde Nordkamp LR, Vink AS, Wilde AA, et al. Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes. Heart Rhythm 2015; 12: 367-375. PMID: 25311410 444. Delise P, Probst V, Allocca G, et al. Clinical outcome of patients with the Brugada type 1 electrocardiogram without prophylactic implantable cardioverter defibrillator in primary prevention: a cumulative analysis of seven large prospective studies. Europace 2018; 20: f77-f85. PMID: 29036426 445. Raju H, Papadakis M, Govindan M, et al. Low prevalence of risk markers in cases of sudden death due to Brugada syndrome relevance to risk stratification in Brugada syndrome. J Am Coll Cardiol 2011; 57: 2340-2345. PMID: 21636035 446. Rattanawong P, Kewcharoen J, Yinadsawaphan T, et al. Type of syncope and outcome in Brugada syndrome: A systematic review and meta-analysis. J Arrhythm 2023; 39: 111-120. PMID: 37021016 447. Asada S, Morita H, Mizuno T, et al. Syncope and loss of consciousness after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: Prevalence and characteristics in longterm follow-up. Heart Rhythm O2 2023; 4: 641-649. PMID: 37936673 448. Kamakura T, Shinohara T, Yodogawa K, et al. Long-term prognosis of patients withJ-wave syndrome. Heart 2020; 106: 299-306. PMID: 31391205 449. Evain S, Briec F, Kyndt F, et al. Sodium channel blocker tests allow a clear distinction of electrophysiological characteristics and prognosis in patients with a type 2 or 3 Brugada electrocardiogram pattern. Heart Rhythm 2008; 5: 1561-1564. PMID: 18984533 450. Sieira J, Conte G, Ciconte G, et al. Clinical characterisation and long-term prognosis of women with Brugada syndrome. Heart 2016; 102: 452-458. PMID: 26740482 451. Milman A, Gourraud JB, Andorin A, et al. Gender differences in patients with Brugada syndrome and arrhythmic events: Data from a survey on arrhythmic events in 678 patients. Heart Rhythm 2018; 15: 1457-1465. PMID: 29908370 452. Imamura T, Makiyama T, Ozawa J, et al. Sex-specific clinical course of young patients with Brugada syndrome. Eur Heart J 2025; 46: 1263-1266. PMID: 39908976 453. Benito B, Sarkozy A, Mont L, et al. Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol 2008; 52: 1567-1573. PMID: 19007594 454. Rodríguez-Mañero M, Casado-Arroyo R, Sarkozy A, et al. The clinical significance of pregnancy in Brugada syndrome. Rev Esp Cardiol (Engl Ed) 2014; 67: 176-180. PMID: 24774391 455. Sharif-Kazemi MB, Emkanjoo Z, Tavoosi A, et al. Electrical storm in Brugada syndrome during pregnancy. Pacing Clin Electrophysiol 2011; 34: e18-e21. PMID: 20353417 456. Suzuki K, Sonoda K, Aoki H, et al. Association Between Deleterious SCN5A Variants and Ventricular Septal Defect in Young Patients With Brugada Syndrome. JACC Clin Electrophysiol 2022; 8: 297-305. PMID: 35331424 457. Gonzalez Corcia MC, Sieira J, Sarkozy A, et al. Brugada syndrome in the young: an assessment of risk factors predicting future events. Europace 2017; 19: 1864-1873. PMID: 27738063 458. Righi D, Porco L, Calvieri C, et al. Clinical characteristics and risk of arrhythmic events in patients younger than 12 years diagnosed with Brugada syndrome. Heart Rhythm 2021; 18: 1691-1697. PMID: 34147702 459. Pannone L, Bisignani A, Osei R, et al. Genetic testing in children with Brugada syndrome: results from a large prospective registry. Europace 2023; 25: euad079. PMID: 37061847 460. Krahn AD, Behr ER, Hamilton R, et al. Brugada Syndrome. JACC Clin Electrophysiol 2022; 8: 386-405. PMID: 35331438 461. Amin AS, Meregalli PG, Bardai A, et al. Fever increases the risk for cardiac arrest in the Brugada syndrome. Ann Intern Med 2008; 149: 216-218. PMID: 18678856 462. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005; 111: 659-670. PMID: 15655131 463. Smith J, Hannah A, Birnie DH. Effect of temperature on the Brugada ECG. Heart 2003; 89: 272. PMID: 12591828 464. BrugadaDrugs.org. https://www.brugadadrugs.org/ 465. Yap YG, Behr ER, Camm AJ. Drug-induced Brugada syndrome. Europace 2009; 11: 989-994. PMID: 19482855 466. Postema PG, Wolpert C, Amin AS, et al. Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm 2009; 6: 1335-1341. PMID: 19716089 467. Araki T, Konno T, Itoh H, et al. Brugada syndrome with ventricular tachycardia and fibrillation related to hypokalemia. Circ J 2003; 67: 93-95. PMID: 12520160 468. Postema PG, Vlaar AP, DeVries JH, et al. Familial Brugada syndrome uncovered by hyperkalaemic diabetic ketoacidosis. Europace 2011; 13: 1509-1510. PMID: 21576130 469. Lei M, Wu L, Terrar DA, et al. Modernized Classification of Cardiac Antiarrhythmic Drugs. Circulation 2018; 138: 1879-1896.